Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Rejects Pregabalin for Nerve Pain

The Scottish Medicines Consortium has completed an appraisal following a re-submission for Lyrica (Pregabalin).

They have concluded that based on current data clinical and cost effectiveness has not been demonstrated for patients who fail to respond to current treatments.

Action: Continue using conventional therapies for the treatment of pain caused by peripheral damage to nerves. Do not use Pregabalin when other treatments fail.

Share 'SMC Rejects Pregabalin for Nerve Pain' on Email Share 'SMC Rejects Pregabalin for Nerve Pain' on Delicious Share 'SMC Rejects Pregabalin for Nerve Pain' on Digg Share 'SMC Rejects Pregabalin for Nerve Pain' on Facebook Share 'SMC Rejects Pregabalin for Nerve Pain' on Google+ Share 'SMC Rejects Pregabalin for Nerve Pain' on reddit Share 'SMC Rejects Pregabalin for Nerve Pain' on StumbleUpon Share 'SMC Rejects Pregabalin for Nerve Pain' on Twitter

atomic-wealth

No Comments to “SMC Rejects Pregabalin for Nerve Pain”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,321 spam comments.

atomic-wealth
fond-illness
summer